Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Rating of “Buy” by Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned a consensus rating of “Buy” from the ten analysts that are covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $28.70.

Several research firms have recently commented on ASPN. Benchmark reissued a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research report on Thursday, August 8th. StockNews.com raised Aspen Aerogels to a “sell” rating in a research report on Thursday, October 31st. TD Cowen boosted their price target on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Roth Mkm reduced their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Finally, Piper Sandler reduced their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

A number of hedge funds have recently modified their holdings of ASPN. BNP Paribas Financial Markets boosted its stake in shares of Aspen Aerogels by 85.2% in the first quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after buying an additional 11,823 shares during the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Aspen Aerogels in the first quarter worth about $1,181,000. Oppenheimer & Co. Inc. purchased a new stake in shares of Aspen Aerogels in the first quarter worth about $388,000. Swiss National Bank boosted its stake in shares of Aspen Aerogels by 16.2% in the first quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock worth $2,121,000 after buying an additional 16,800 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Aspen Aerogels by 5.1% in the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after buying an additional 175,906 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Price Performance

Shares of ASPN stock opened at $15.80 on Wednesday. Aspen Aerogels has a twelve month low of $8.79 and a twelve month high of $33.15. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of 1,588.59 and a beta of 2.21. The stock has a fifty day simple moving average of $22.87 and a two-hundred day simple moving average of $24.74. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.